<DOC>
	<DOC>NCT01364194</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of periarticular injection with 0.25% bupivacaine for controlling pain after total knee replacement to improve the quality of post-operative care.</brief_summary>
	<brief_title>Local Infiltration With Bupivacaine to Increase Quality of Post-operative Pain Control in Total Knee Replacement</brief_title>
	<detailed_description>Compare post operative pain control after total knee replacement by periarticular injection with 0.25% bupivacaine compare with 0.9% normal saline.</detailed_description>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>primary osteoarthritis patients undergoing total knee replacement at Siriraj Hospital BMI between 2035 having a full understanding of the question in this trial allergy to NSAIDs, Acetaminophen, Bupivacaine blood creatinine more than 1.5 mg/dl or creatinine clearance less than 60 mL/min abnormal liver function previous surgery on the knee undergoing total knee replacement patient could not receive spinal anesthesia</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Post operative pain</keyword>
	<keyword>Total knee replacement</keyword>
	<keyword>Total knee arthroplasty</keyword>
	<keyword>Bupivacaine</keyword>
	<keyword>Periarticular injection</keyword>
	<keyword>Placebo</keyword>
	<keyword>Morphine consumption</keyword>
</DOC>